F. Jalali, D. Moslemi, and A. Farjam, “First Study of the Safety and Tolerability of Allvec-1, a Gene Therapy Vector, in Patients With Advanced Stage IV Malignant Solid Tumors”, Reports-of-Radiotherapy-and-Onco, vol. 2, no. 1, pp. 1-6, Jan. 2015.